Temple now offers a new treatment for Obstructive Sleep Apnea (OSA) for patients who can’t tolerate continuous positive air pressure (C-PAP). The FDA-approved Inspire® system is an implantable device that keeps a patient’s airway open while they sleep.
Patients with OSA briefly stop breathing while they’re asleep, often many times per night. Normally, when people sleep, the muscles of their throats relax but their airways remain open. However, the airway becomes blocked in patients with OSA, and their breathing briefly stops. The constant cycle of loss of air, waking to resume breathing, and sleeping again, often leads to poor rest and daytime drowsiness.
With Inspire, the device monitors every breath you take while you’re asleep. Based on your breathing patterns, the system delivers mild stimulation to the nerve that controls key airway muscles. By stimulating these muscles, your airway stays open while you sleep.
The Inspire obstructive sleep apnea device is operated by a small handheld sleep remote. The remote lets you turn Inspire therapy on before bed and off when you wake up, increase and decrease stimulation strength, and pause during the night if needed.